Tag Archives: Patient Compliance

Fixed-Dose Combination of Memantine Extended Release and Donepezil for Alzheimer’s Disease: Licensing Application Submitted to FDA (Biospace Inc.)

Summary A new drug application has been submitted to the FDA (in the United States) for a fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer’s Disease dementia. “Using the two drugs together … Continue reading

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments, Quick Insights | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Pharmacist-Based Donepezil Outpatient Consultation Service (Patient Preference and Adherence)

[A brief reference to this item appears in: Dementia and Elderly Care: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 3, October 2012]. Summary Donepezil delays the progression of cognitive dysfunction in Alzheimer’s Disease (AD), but the efficacy of pharmacotherapy … Continue reading

Posted in Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Pharmacological Treatments, Quick Insights | Tagged , , , , , , , , , , , , , , , , | Leave a comment